Diverse types of glutamatergic pyramidal neurons mediate the myriad processing streams and output channels of the cerebral cortex1,2, yet all derive from neural progenitors of the embryonic dorsal telencephalon3,4. Here we establish genetic strategies and tools for dissecting and fate-mapping subpopulations of pyramidal neurons on the basis of their developmental and molecular programs. We leverage key transcription factors and effector genes to systematically target temporal patterning programs in progenitors and differentiation programs in postmitotic neurons. We generated over a dozen temporally inducible mouse Cre and Flp knock-in driver lines to enable the combinatorial targeting of major progenitor types and projection classes. Combinatorial strategies confer viral access to subsets of pyramidal neurons defined by developmental origin, marker expression, anatomical location and projection targets. These strategies establish an experimental framework for understanding the hierarchical organization and developmental trajectory of subpopulations of pyramidal neurons that assemble cortical processing networks and output channels.
Pyramidal neurons (PyNs) constitute the large majority of nerve cells in the cerebral cortex and mediate all of the inter-areal processing streams and output channels1,2,4. Traditionally, PyNs have been classified into several major classes according to their laminar location and broad axon projection targets, such as intratelencephalic (IT) and extratelencephalic (ET or corticofugal), which further comprises subcerebral (including pyramidal tract; PT) and corticothalamic (CT) PyNs1. Within these classes, subsets of PyNs form specific local and long-range connectivity, linking discrete microcircuits to cortical subnetworks and output channels1,5. Single-cell transcriptome analysis suggests that there are over fifty PyN transcriptomic types6. However, genetic tools and strategies for experimentally accessing PyN subpopulations are limited.
All PyNs are generated from neural progenitors in the embryonic dorsal telencephalon, where regionally differentiated radial glial progenitors (RGs) undergo asymmetric divisions, giving rise to radial clones of PyNs that migrate to the cortex in an inside-out order7. RGs generate PyNs either directly or indirectly through intermediate progenitors (IPs), which divide symmetrically to generate pairs of PyNs8. A set of temporal patterning genes drive lineage progression in RGs, which unfold a conserved differentiation program in successively generated postmitotic neurons3,4,9. Resolving the lineage organization of diverse progenitors and their relationship to projection-defined PyN subpopulations requires fate-mapping tools with cell type and temporal resolution2.
Here we present strategies and a genetic toolkit in the mouse for targeting PyN subpopulations and progenitors guided by knowledge of their developmental programs. We leverage gene expression patterns of the cell-type specification and differentiation programs to target biologically significant progenitor subsets, PyN subpopulations and their developmental trajectories (Fig. 1a–c, Extended Data Table 1). These tools and strategies provide a roadmap for accessing hierarchically organized PyN types at progressively finer resolution. They will facilitate the tracking of developmental trajectories of PyNs for elucidating the organization and assembly of neural circuits of the cerebral hemisphere, including the cortex, hippocampus and basolateral amygdala.
Fate-mapping PyN progenitors
The transcription factors LHX2 and FEZF2 act at multiple stages throughout corticogenesis10,11,12. The fate potential of and relationship between Lhx2+ RGs (RGsLhx2) and Fezf2+ RGs (RGsFezf2) are largely unknown. We generated Lhx2-CreER, Fezf2-CreER and Fezf2-Flp driver lines and performed a series of fate-mapping experiments at multiple embryonic stages to reveal these progenitors and their lineage progression, as well as their PyN progeny in the mature cortex (Fig. 1d–h, Extended Data Figs. 1, 2).
At embryonic day (E) 10.5, a 24-hour tamoxifen pulse-chase in Lhx2-CreER;Ai14 embryos resulted in dense labelling of neuroepithelial cells and RGs in the dorsal pallium, with a sharp border at the cortex–hem boundary (Extended Data Fig. 1a). E12.5–E13.5 pulse-chase revealed a prominent medialhigh to laterallow gradient of RGsLhx2 (Fig. 1d), suggesting differentiation of the earlier RGs. E13.5–E14.5 pulse-chase showed a similar gradient pattern at a lower cell density (Extended Data Fig. 1e). Fate-mapping from E10.5–P30, E12.5–P30 and E14.5–P30 labelled PyN progeny across cortical layers (Fig. 1e, Extended Data Fig. 1b–f, p), suggesting multipotency of RGsLhx2 at these stages. During postnatal development, the expression of Lhx2 became postmitotic: pulse-chase in P5 labelled largely IT PyNs across layers and in the second postnatal week labelled more astrocytes (around 60%) than PyNs across layers (Extended Data Fig. 1q–r).
Similar fate-mapping experiments using the Fezf2-CreER driver yielded contrasting results. At E10.5, short pulse-chase labelled only a sparse set of pallial RGs, ending at the cortex–hem boundary (Extended Data Fig. 1g). E12.5–E13.5 pulse-chase labelled a larger set of RGsFezf2 with a similar medialhigh to laterallow gradient as RGsLhx2, with a notably lower density (Fig. 1f). E13.5–E14.5 pulse-chase labelled few RGs, primarily in the medial region, and otherwise postmitotic PyNs (Extended Data Fig. 1k). Fate-mapping from E10.5–P30 and E12.5–P30 labelled PyNs across cortical layers, suggesting multipotent RGsFezf2 (Fig. 1g, Extended Data Fig. 1h, j). After E13.5, the expression of Fezf2 largely shifted to postmitotic layer (L) 5 and 6 (L5/6) corticofugal PyNs (Extended Data Fig. 1l). Both the Lhx2-CreER and the Fezf2-CreER drivers recapitulate endogenous expression across developmental stages (Extended Data Fig. 2), thus providing fate-mapping tools for these progenitor pools.
To probe the relationship between RGsLhx2 and RGsFezf2, we designed an intersection–subtraction (IS) strategy. Combining Lhx2-CreER and Fezf2-Flp with an IS reporter13, we differentially labelled RGsLhx2+/Fezf2− and RGsLhx2+/Fezf2+ (Fig. 1i–n, Extended Data Fig. 1s, t). E11.5–E12.5 and E12.5–E13.5 pulse-chase revealed two distinct RG subpopulations intermixed across the dorsal pallium, with RGsLhx2+/Fezf2− more than twice as abundant as RGsLhx2+/Fezf2+. Both subpopulations distributed in a medialhigh to laterallow and rostralhigh to caudallow gradient, consistent with the patterns of Lhx2 and Fezf2 expression (Fig. 1j, k). Although most RGsFezf2 expressed LHX2, approximately 10% did not (Extended Data Fig. 2e, i), suggesting that there are three distinct RG subpopulations distinguished by differential expression of Lhx2 and Fezf2. Notably, long pulse-chase revealed that whereas RGsLhx2+/Fezf2−-derived PyNs extended callosal but no subcortical axons—the IT type—RGsLhx2+/Fezf2+-derived PyNs extended subcortical but no callosal axons—the ET type (Fig. 1l–n). This result suggested fate-restricted RG lineages that produce categorically distinct PyN projection classes.
Early cortical progenitors comprise proliferative and neurogenic subpopulations. Tis21 (also known as Btg2) is a transcription co-regulator that is expressed in both pallium-derived glutamatergic and subpallium-derived GABAergic neurogenic RGs (nRGs)14. E10.5 fate-mapping in the Tis21-CreER driver line labelled columnar clones of PyNs and astrocytes intermixed with subpallium-derived GABAergic interneurons (Extended Data Fig. 3b, f, g). We used Tis21-CreER;Fezf2-Flp;IS mice to restrict fate-mapping to glutamatergic neurogenic RGs (Extended Data Fig. 3h–k). E11.5–E12.5 pulse-chase demonstrated that Tis21–Fezf2 intersection specifically labelled a set of pallial nRGFezf2+ with enhanced green fluorescent protein (EGFP), whereas Tis21–Fezf2 subtraction labelled pallial and subpallial nRGFezf2− with red fluorescent protein (RFP). Pallial nRGs consisted of both Fezf2+and Fezf2− subpopulations, suggesting heterogeneity. E12.5–P30 fate-mapping in these mice revealed three types of PyN clones (Extended Data Fig. 3i-k). RFP-only clones are likely to have derived from nRGFezf2− in which Tis21-CreER activated RFP expression; they probably consisted of PyNs that did not express Fezf2 at any stage. EGFP-only clones are likely to have derived from nRGFezf2+, in which Tis21-CreER and Fezf2-Flp co-expression activated EGFP in the IS reporter allele. Mixed clones containing both EGFP and RFP cells probably derived from nRGFezf2− in which Tis21-CreER activated RFP expression followed by postmitotic activation of EGFP through Fezf2-Flp. Together, these results indicate the presence of nRGFezf2+ and nRGFezf2−, both multipotent in generating PyNs across all cortical layers.
IPs and indirect neurogenesis have evolved largely in the mammalian lineage and have further expanded in primates14,15. Along the neural tube, IP-mediated indirect neurogenesis is restricted to the telencephalon and is thought to contribute to the expansion of cell numbers and diversity in the neocortex. The majority of PyNs in mouse cortex are produced through IPs16,17, but the link between indirect neurogenesis and PyN types remains unclear. The T-box transcription factor Tbr2 (also known as Eomes) is expressed in pallial IPs throughout indirect neurogenesis18. E16.5 pulse-chase in the Tbr2-CreER driver line specifically labelled IPs (Extended Data Fig. 3a, c). E16.5 and E17.5 fate-mapping labelled PyNs in L2/3 and upper L2, respectively (Fig. 2c, d, Extended Data Fig. 3d). Therefore, the Tbr2-CreER driver enables highly restricted laminar targeting of PyN subpopulations in supragranular layers. Furthermore, Tis21-CreER and Tbr2-FlpER intersection enabled specific targeting of neurogenic but not the transit-amplifying IPs (Extended Data Fig. 3a, e). Altogether, these progenitor driver lines facilitate dissecting progenitor diversity and tracking the developmental trajectories of PyNs from their lineage origin to circuit organization.
Targeting PyN subpopulations
We generated driver lines targeting PyN subpopulations and characterized these in comparison to existing lines where feasible (Fig. 2, Extended Data Table 1, Extended Data Fig. 4, Supplementary Tables 1, 2). These tamoxifen-inducible drivers confer temporal control and dose-dependent labelling and manipulation from individual cells to dense populations.
IT PyNs constitute the largest top-level class and mediate intracortical and corticostriatal communication streams1,19,20,21. Cux1 and Cux2 are predominantly expressed in supragranular IT PyNs and their progenitors22,23. In our Cux1-CreER;Ai14 mice, postnatal tamoxifen induction prominently labelled L2–L4 PyNs dorsal to the rhinal fissure as well as a set of hippocampal PyNs, recapitulating the endogenous pattern (Fig. 2a, Extended Data Fig. 4, Supplementary Video 1). Anterograde tracing revealed that PyNsCux1 in somatosensory barrel cortex (SSp-bfd or SSp) projected predominantly to the ipsi- and contralateral cortex, with only very minor branches in the striatum (Fig. 3a, d, Extended Data Fig. 7, Supplementary Video 2). Compared with existing IT drivers (Extended Data Figs. 4, 5, Supplementary Tables 1, 2), Cux1-CreER is unique in targeting predominantly cortex- but not striatum-projecting IT subpopulations.
The supragranular layers comprise diverse IT types20, but only a few L2/3 drivers have been reported so far24 and none distinguish L2 versus L3 PyNs. We used a lineage and birth dating approach to dissect L2/3 PyNs. In our Tbr2-CreER driver targeting IPs, tamoxifen induction at E16.5 and E17.5 specifically labelled PyNs in L2/3 and L2, respectively (Fig. 2c, d). Combined with the CreER to Flp conversion strategy that converts lineage and birth timing signals to permanent Flp expression13, this approach enables adeno-associated virus (AAV) manipulation of L2 and L3 IT neurons.
The plexin D1–semaphorin 3E receptor–ligand system has been implicated in axon guidance and synapse specification25,26. In developing and mature cortex, Plxnd1 (encoding plexin D1) is expressed in large sets of IT PyNs10. Plxnd1-CreER and Plxnd1-Flp driver lines recapitulated endogenous expression and labelled projection neurons in the cerebral cortex, hippocampus, amygdala and striatum (Figs. 2b, 4e, Extended Data Figs. 4, 5a, Supplementary Tables 3, 4, Supplementary Videos 3, 4); in the neocortex, L5A and L2/3 IT PyNsPlxnd1 were labelled (Fig. 2b, Extended Data Fig. 6a–c). As Plxnd1 is also expressed in vascular cells, we bred Plxnd1-CreER mice with the neuron-specific reporter Snap25-LSL-EGFP to selectively label Plxnd1+PyNs (PyNsPlxnd1; Fig. 2b). Anterograde tracing from SSp-bfd revealed that PyNsPlxnd1 project to ipsi- and contralateral cortical and striatal regions (Fig. 3a, d, Extended Data Fig. 7a–c, f, Supplementary Tables 5–7, Supplementary Video 5). Thus, Plxnd1 drivers confer access to this major IT subpopulation and to Plxnd1+ subpopulations in the striatum and amygdala.
After early expression in a subset of dorsal pallial progenitors, Fezf2 becomes restricted to postmitotic L5/6 corticofugal PyNs, with higher levels in L5B PT neurons and lower levels in a subset of CT neurons10,27. At postnatal stages, Fezf2 drivers labelled projection neurons in the cerebral cortex, hippocampus, amygdala, and olfactory bulb (Extended Data Fig. 4, Supplementary Table 4, Supplementary Video 6). Within the neocortex, PyNsFezf2 reside predominantly in L5B and to a lesser extent in L6 (Fig. 2e, 1, Extended Data Figs. 4a, d, 6d–f); PyNsFezf2 are absent below the rhinal fissure (Supplementary Table 4, Supplementary Video 6). Anterograde tracing of PyNsFezf2 in SSp-bfd revealed projections to numerous somatomotor cortical (for example, ipsilateral vibrissal secondary motor area (MOs)) and subcortical regions including the striatum, thalamic ventral posteromedial nucleus of the thalamus (VPM) and posterior complex of the thalamus (PO), anterior pretectal nucleus, ipsilateral superior colliculus (iSC), pontine nucleus, corticospinal tract (CST) and contralateral spinal trigeminal nucleus (cSp5) (Fig. 3b, e, Extended Data Figs. 7a, b, d, f, 8f–r, Supplementary Tables 5, 6, Supplementary Video 7).
We further generated several lines targeting finer PT subpopulations. In Adcyap1- and Tcerg1l-CreER drivers, late embryonic induction labelled L5B subpopulations that project only to ipsilateral cortical targets and to a subset of targets innervated by PyNFezf2 (Figs. 2f, g, 3b, e, Extended Data Figs. 4, 6d–f, 7a, b, d, f, Supplementary Tables 4–6, Supplementary Videos 8–11). In Sema3e-CreER (ref. 28), postnatal induction labelled a subset of L5B PyNs that project to more-restricted subcortical areas, namely higher-order thalamic nucleus POm and pontine nucleus (Extended Data Figs. 4d, 8a–e, Supplementary Tables 4, 5, Supplementary Video 12). Together, the new set of PT drivers will enable a finer hierarchical dissection of molecularly and anatomically defined PT types.
Tbr1 is expressed in postmitotic L6 CT neurons and represses the expression of Fezf2 and Ctip2 (also known as Bcl11b) to suppress the PT fate3,29. In Tbr1-CreER;Ai14 mice, tamoxifen induction at P4 marked L6 CT neurons densely, with sparse labelling in L2/3, cerebral nuclei, hippocampus, piriform cortex and amygdala (Fig. 2h, Extended Data Fig. 4a–c, Supplementary Table 4, Supplementary Video 13). PyNsTbr1 from SSp-bfd projected to multiple thalamic targets, including primary and higher order nuclei, as well as reticular nucleus of the thalamus (Fig. 3c, f, Supplementary Tables 5, 6, Supplementary Video 14). Consistent with a study showing that some PyNsTbr1 project to the contralateral cortex30, we found labelling in the corpus callosum (Extended Data Fig. 6). It remains to be determined whether PyNsTbr1 with contralateral projections (Fig. 3f) represent a distinct type.
Tle4 is a transcription corepressor that is expressed in a subset of CT PyNs31,32. Our Tle4-CreER driver specifically labelled L6 CT PyNs across the cortex (Fig. 2i, Extended Data Figs. 4, 6d–f, Supplementary Table 4, Supplementary Video 15). Tle4 is also expressed in medium spiny neurons of the striatum, olfactory bulb, hypothalamus, iSC, cerebellum and septum (Extended Data Fig. 4c, Supplementary Table 4, Supplementary Video 15). PyNsTle4 in SSp-bfd specifically projected to first-order thalamic VPM and reticular nucleus of the thalamus (Fig. 3c, f, Extended Data Fig. 7a, b, e, f, Supplementary Table 4, Supplementary Video 16).
Foxp2 is expressed in many CT neurons from the postmitotic stage to the mature cortex33,34,35. In adult Foxp2-IRES-Cre mice36, systemic injection of Cre-dependent AAV9-DIO-GFP specifically labelled L6 PyNs; Foxp2+ cells were also found in the striatum, thalamus, hypothalamus, midbrain, cerebellum and inferior olive (Fig. 2j, Extended Data Fig. 4a–c, Supplementary Table 4, Supplementary Video 17). PyNFoxp2 in SSp-bfd projected to thalamus, tectum and some ipsilateral cortical areas (Fig. 3c, f, Supplementary Tables 4, 5, Supplementary Video 18). Compared to PyNsTle4, PyNsFoxp2 projected more broadly to the thalamus, largely overlapping with PyNTbr1 axons.
To further characterize several PyN driver lines, we performed a set of histochemical analyses (Extended Data Fig. 6). PyNs targeted in Fezf2, Tcerg1l and Adcyap1 drivers extensively co-labelled with PT markers. PyNs targeted in Tle4 and Tbr1 drivers co-labelled with CT markers. The laminar patterns and class-specific marker expression in these driver lines precisely recapitulated endogenous patterns (in situ hybridization data in the Allen Brain Map: Mouse Brain Atlas; https://mouse.brain-map.org/search/index), providing further evidence of the reliability and specificity of these driver lines.
Combinatorial targeting of projection types
To further dissect driver-line-defined subpopulations according to projection targets, we first used retrograde tracing. Within the PT population, retroAAV and fluorogold injections in the spinal cord of Fezf2-CreER mice specifically labelled L5B corticospinal PyNs in the sensorimotor cortex (Extend Data Fig. 10a–c, Supplementary Table 6). To explore PyNsFezf2 subpopulations jointly defined by projection targets and sublaminar position, we used the IS reporter13. Consistent with previous findings37, PyNsFezf2 that project to the thalamus and medulla resided in the upper and lower sublamina of L5B in the primary motor area (MOp), respectively (Extended Data Fig. 9d–f). In SSp-bfd, PyNsFezf2 with collaterals to the striatum resided in upper L5, those with collaterals to the superior colliculus or cSp5 resided in the middle and lower portion of L5B, and those projecting to thalamic POm resided both in middle to lower L5B and in L6 (Extended Data Fig. 9g–h, l–o). We then distinguished subsets of L5B PyNsFezf2 according to their expression of the calcium-binding protein parvalbumin using Fezf2-CreER;Pv-Flp;IS mice that differentially labelled PyNsFezf2+/PV− and PyNsFezf2+/PV+ (in which PV represents parvalbumin; this gene is also known as Pvalb) (Extended Data Fig. 9i, j). Compared to PyNsFezf2+/PV−, PyNsFezf2+/PV+ exhibited more depolarized resting membrane potentials. In addition, we designed a strategy (triple trigger) to target PyNsFezf2 jointly defined by a driver line, a projection target and a cortical location (Extended Data Fig. 10).
We also used retroAAV to dissect the CT and IT populations. In Tle4-CreER;IS mice, retrograde tracing from the thalamic VPM revealed two subpopulations of L6 PyNsTle4, one extending apical dendrites to the L4/5 border, the other to L1 (Extended Data Fig. 9q), suggesting differential inputs. In Plxnd1-CreER mice (Extended Data Fig. 9p, r–w), whereas L5A PyNsPlxnd1 projected to both the ipsi- and the contralateral striatum, L2/3 PyNsPlxnd1 projected mostly to the ipsilateral striatum.
In addition, consistent with the finding that some PyNsFezf2 extend contralateral cortical and striatal projections (Fig. 3e), retrograde cholera toxin subunit B (CTB) tracing from the striatum labelled a set of contralateral PyNsFezf2+ at the L5A–L5B border (Extended Data Fig. 11a–e), a characteristic IT feature. Indeed, a small set of PyNs at the L5A–L5B border co-expressed Fezf2 and Plxnd1 mRNAs; these PyNsFezf2/Plxnd1 occupied the very top sublayer of the PyNFezf2 population (Extended Data Fig. 11f–h), and thus probably contributed to their contralateral cortical and striatal projections (Fig. 3a, b, d, e). Single-cell reconstruction may reveal whether PyNsFezf2/Plxnd1 are typical IT cells or also project subcortically and represent an ‘intermediate PT-IT’ type.
Finally, we show highly specific targeting of PyN subtypes by combining their developmental, molecular and anatomical attributes. PyNsPlxnd1 localize to L5A, L3 and L2 and project to numerous ipsilateral and contralateral cortical and striatal targets (Figs. 2b, 3a, d, Extended Data Figs. 4, 7). We developed a method (Fig. 4a) to dissect PyNPlxnd1 subtypes on the basis of the developmental principle that PyN birth order correlates with laminar position and the observation that the majority of IT PyNs are generated from IPs17. In Plxnd1-Flp;Tbr2-CreER;Ai65 mice, the constitutive Plxnd1-Flp allele marks the whole population (Fig. 4e) and the inducible Tbr2-CreER allele enables birth dating (Fig. 4a). Notably, tamoxifen induction at E13.5, 15.5 and 17.5 selectively labelled L5Aand progressively more superficial PyNsPlxnd1 (Fig. 4b–d). We then bred Plxnd1-Flp;Tbr2-CreER;dual-tTA mice for anterograde tracing of projection patterns (Fig. 4f). AAV-TRE3g-mRuby injection into SSp-bfd in E13.5- and 17.5-induced mice labelled distinct subtypes of PyNsPlxnd1 with different projection patterns. E13.5-born PyNsPlxnd1(E13.5) resided in L5A and projected ipsilaterally to multiple cortical areas, contralaterally to homotypic SSp-bfd cortex and heterotypic cortical areas, and bilaterally to the striatum (Fig. 4g–m, u). By contrast, E17.5-born PyNsPlxnd1(E17.5) resided in L2; although they also extended strong projections to ipsilateral cortical and striatal targets and to the homotypic contralateral cortex, they had minimal projections to the heterotypic contralateral cortex and striatum (Fig. 4n–u). These birth-dated PyNPlxnd1 subsets further differed in their axon termination patterns within a cortical target area. Whereas PyNPlxnd1(E13.5) axons terminated throughout the thickness of L1 and L2/3, with few axon branches in L5A, PyNPlxnd1(E17.5) axons terminated strongly in L2/3 and L5A, with few branches in L1 (Fig. 4l–m, s–u). Thus, even within the same target areas, birth-dated PyNsPlxnd1 may preferentially select different postsynaptic cell types and/or subcellular compartments.
Together with previous resources24,38,39, the PyN driver lines we present here provide much improved specificity, coverage and robustness for a systematic dissection of PyN organization from broad subclasses to finer types. By focusing on driver lines that recapitulate the expression of key transcription factors and effector genes that are implicated in specification and differentiation, these tools will enable the dissection and fate-mapping of biologically significant subpopulations of PyNs through their inherent developmental, anatomical and physiological properties; that is, ‘carving nature at its joints’. The precision and reliability of these drivers also allows the combinatorial targeting of finer projection types through the intersection of molecular, developmental and anatomical properties. The inducibility of driver lines enhances the specificity and flexibility of cell targeting, manipulation and fate-mapping. Inducibility also allows control over the density of labelling and manipulation, from dense coverage to single-cell analysis—the ultimate resolution for clarifying the stereotypical and variable features of neurons within marker-defined subpopulations40,41,42. Temporal control allows gene manipulations at different developmental stages to discover the cellular and molecular mechanisms of circuit development and function. Together, these tools and strategies establish a roadmap for dissecting the hierarchical organization of PyN types on the basis of their inherent biology. The incorporation of recently developed enhancer AAVs43 with these driver lines may further increase the specificity, ease and throughput of cell-type access.
Several transcription factors used in this study (for example, Cux1, Fezf2, Tbr1, Tbr2 and Foxp2) continue to evolve and diverge in primates44 and are implicated in developmental disorders such as autism23,35. Our transcription factor driver lines provide handles to track the developmental trajectories of PyN subpopulations in cortical circuit assembly, with implications in the cross-species evolution of PyNs and for deciphering the genetic architecture of neurodevelopmental disorders.
No statistical methods were used to predetermine sample size. The experiments were not randomized and the investigators were not blinded to allocation during experiments and outcome assessment.
Generation of knock-in mouse lines
Driver and reporter mouse lines listed in Supplementary Table 1 were generated using a PCR-based cloning, as described before and below13,45. All experimental procedures were approved by the Institutional Animal Care and Use Committee (IACUC) of the Cold Spring Harbor Laboratory (CSHL) in accordance with NIH guidelines. Mouse knock-in driver lines are deposited at The Jackson Laboratory for wide distribution. Knock-in mouse lines were generated by inserting a 2A-CreER or 2A-Flp cassette in-frame before the STOP codon of the targeted gene. Targeting vectors were generated using a PCR-based cloning approach as described before. In brief, for each gene of interest, two partially overlapping BAC clones from the RPCI-23&24 library (made from C57BL/b mice) were chosen from the Mouse Genome Browser. The 5′ and 3′ homology arms were PCR-amplified (2–5 kb upstream and downstream, respectively) using the BAC DNA as template and cloned into a building vector to flank the 2A-CreERT2 or 2A-Flp expressing cassette as described47. These targeting vectors were purified and tested for integrity by enzyme restriction and PCR sequencing. Linearized targeting vectors were electroporated into a 129SVj/B6 hybrid embryonic stem (ES) cell line (v6.5). ES clones were first screened by PCR and then confirmed by Southern blotting using appropriate probes. DIG-labelled Southern probes were generated by PCR, subcloned and tested on wild-type genomic DNA to verify that they give clear and expected results. Positive v6.5 ES cell clones were used for tetraploid complementation to obtain male heterozygous mice following standard procedures. The F0 males were bred with reporter lines (Supplementary Tables 1, 3, 4) and induced with tamoxifen at the appropriate ages to characterize the resulting genetically targeted recombination patterns.
Tamoxifen (T5648, Sigma) was prepared by dissolving in corn oil (20 mg ml−1) and applying a sonication pulse for 60 s, followed by constant rotation overnight at 37 °C. Embryonic inductions for most knock-in lines were done in the Swiss-Webster background; inductions for Tis21-CreER, Fezf2-Flp intersection experiments were done in the C57BL6 background. E0.5 was established as noon on the day of vaginal plug and tamoxifen was administered to pregnant mothers by gavage at a dose varying from 2–100 mg kg−1 at the appropriate age. For embryonic collection (12–24 h pulse-chase experiments), a dose of 2mg kg−1 was administered to pregnant dams via oral gavage. For postnatal induction, a 100–200 mg kg−1 dose was administered by intraperitoneal injection at the appropriate age.
Postnatal and adult mice were anaesthetized (using Avertin) and intracardially perfused with saline followed by 4% paraformaldehyde (PFA) in 0.1 M PB. After overnight post-fixation at 4 °C, brains were rinsed three times and sectioned at a 50–75-µm thickness with a Leica 1000s vibratome. Embryonic brains were collected in PBS and fixed in 4% PFA for 4 h at room temperature, rinsed three times with PBS, dehydrated in 30% sucrose-PBS, frozen in OCT compound and cut by cryostat (Leica, CM3050S) in 20–50-µm coronal sections. Early postnatal pups were anaesthetized using cold shock on ice and intracardially perfused with 4% PFA in PBS. Post-fixation was performed similarly to older mice. Postnatal mice aged 1–2 months were anaesthetized using Avertin and intracardially perfused with saline followed by 4% PFA in PBS; brains were post-fixed in 4% PFA overnight at 4 °C and subsequently rinsed three times, embedded in 3% agarose-PBS and cut to a 50–100-μm thickness using a vibrating microtome (Leica, VT100S). Sections were placed in blocking solution containing 10% normal goat serum (NGS) and 0.1% Triton-X100 in PBS1X for 1 h, then incubated overnight at 4 °C with primary antibodies diluted in blocking solution. Sections were rinsed three times in PBS and incubated for 1 h at room temperature with corresponding secondary antibodies (1:500, Life Technologies). Sections were washed three times with PBS and incubated with DAPI for 5 min (1:5,000 in PBS, Life Technologies, 33342) to stain nuclei. Sections were dry-mounted on slides using Vectashield (Vector Labs, H1000) or Fluoromount (Sigma, F4680) mounting medium.
To perform molecular characterization of GeneX-CreER mouse lines, we stained 40-µm vibratome sections for CUX1 and CTIP2, that were imaged in a Nikon Eclipse 90i fluorescence microscope. Focusing on the somatosensory cortex, we counted tdTomato+ cells in a column of around 300-µm width and determined their relative position along the dorso-ventral axis that goes from the ventricular surface (0) to the pia (100%). As a reference, CTIP2+ and CUX1+ regions were plotted as green and blue bars, where the upper limits correspond to the mean relative position of the dorsal-most positive cells, and the lower limits correspond to the mean relative position of the ventral-most positive cells. Grey areas in histograms correspond to the s.d. of those limits. The frequency of tdTomato+ cells along the dorso-ventral axis was plotted in a histogram with a bin width of 5%. Number of cells: Fezf2-CreER, 2,781 cells; Tcerg1l-CreER, 185 cells; Adcyap1-CreER, 54 cells; Tle4-CreER, 2,737 cells; Lhx2-CreER, 1,380 cells; Plexind1-CreER, 809 cells; Cux1-CreER, 2,296 cells; Tbr1-CreER, 3,572 cells; Tbr2-CreER tamoxifen E16.5, 1,273 cells; Tbr2-CreER tamoxifen E17.5, 1,871 cells. For each line we quantified at least four sections from two embryos. Differences in cell numbers are due to differences in labelling density.
For colocalization determination, we obtained confocal z-stacks centred in layer 5 or 6 of the somatosensory cortex, of 320 × 320 × 40 µm3 volumes. For all tdTomato+ cells in the volume, we manually determined whether they were also positive for the desired markers by looking in individual z-planes. The percentage of positive cells was calculated for each area. Average number of tdTomato+ cells quantified per staining: Fezf2-CreER, 314 cells in layer 5 and 472 in layer 6; Tcerg1l-CreER, 162 cells; Adcyap-CreER, 20 cells; Tle4-CreER, 157 cells in layer 5 and 1,081 in layer 6; Lhx2-CreER, 294 cells; Plexind1-CreER, 468 cells in layers 4 and 5a; Cux1-CreER, 761 cells; Tbr1-CreER, 858 cells; Tbr2-CreER, 1,380 cells. For each line we quantified at least four sections from at least two embryos. Differences in cell numbers are due to differences in labelling density.
Anti-GFP (1:1,000, Aves, GFP-1020), anti-RFP (1:1,000, Rockland Pharmaceuticals, 600-401-379), anti-mCherry (1:500, OriGene AB0081-500), anti-mKATE2 for Brainbow 3.0 (a gift from D. Cai), anti-SATB2 (1:20, Abcam ab51502), anti-CTIP2 (1:100, Abcam 18465), anti-CUX1 (1:100, SantaCruz 13024), anti-LDB2 (1:200, Proteintech 118731-AP), anti-FOG2 (1:500, SantaCruz m-247), anti-LHX2 (1:250, Millipore-Sigma ABE1402) and anti-TLE4 (1:300, Santa Cruz sc-365406) were used.
Validation of PyN driver lines
ViewRNA tissue Assay (Thermo Fisher Scientific) fluorescent in situ hybridization (FISH) was carried out as per the manufacturer’s instructions on genetically identified PyNs expressing H2bGFP nuclear reporter (GeneX-CreER;LSL-H2bGFP) to validate the expression of PyN mRNA within Cre-recombinase dependent H2bGFP expressing cells in adult tissue (p24). Antibody validation with Cre-recombinase dependent reporter (GeneX-CreER;Ai14) was also used as it was available for use in adult tissue. For both FISH and antibody validation experiments, the percentage of total recombinase-dependent reporter-positive cells co-expressing PyN driver transcript or antibody was quantified.
Viral injection and analysis
Stereotaxic viral injection
Adult mice were anaesthetized by inhalation of 2% isofluorane delivered with a constant air flow (0.4 l min−1). Ketoprofen (5 mg kg−1) and dexamethasone (0.5 mg kg−1) were administered subcutaneously as preemptive analgesia and to prevent brain oedema, respectively, before surgery, and lidocaine (2–4 mg kg−1) was applied intra-incisionally. Mice were mounted in a stereotaxic headframe (Kopf Instruments, 940 series or Leica Biosystems, Angle Two). Stereotactic coordinates were identified (Supplementary Table 5). An incision was made over the scalp, a small burr hole drilled in the skull and brain surface exposed. Injections were performed according to the strategies delineated in Supplementary Table 5. A pulled glass pipette tip of 20–30 μm containing the viral suspension was lowered into the brain; a 300–400 nl volume was delivered at a rate of 30 nl min−1 using a Picospritzer (General Valve Corp); the pipette remained in place for 10 min preventing backflow, prior to retraction, after which the incision was closed with 5/0 nylon suture thread (Ethilon Nylon Suture, Ethicon) or Tissueglue (3M Vetbond), and mice were kept warm on a heating pad until complete recovery.
Systemic AAV injection
Foxp2-IRES-Cre mice were injected through the lateral tail vein at 4 weeks of age with a 100 µl total volume of AAV9-CAG-DIO-EGFP (UNC Viral Core) diluted in PBS (5 × 1011 vg per mouse). Three weeks after injection, mice were transcardially perfused with 0.9% saline, followed by ice-cold 4% PFA in PBS, and processed for serial two-photon (STP) tomography.
AAVs serotype 8, 9, DJ PHP.eB or rAAV2-retro (retroAAV) packaged by commercial vector core facilities (UNC Vector Core, ETH Zurich, Biohippo, Penn, Addgene) were used as listed in Supplementary Table 5. In brief, for cell-type-specific anterograde tracing, we used either Cre- or Flp-dependent or tTA-activated AAVs combined with the appropriate reporter mouse lines28 (Supplementary Table 7), or dual-tTA (Fig. 4 and Extended Data Fig. 10) to express EGFP, EYFP or mRuby2 in labelled axons. retroAAV-Flp was used to infect axons at their terminals46 in target brain structures to label PyNs retrogradely according to the experiments detailed in Supplementary Table 5.
Microscopy and image analysis
Imaging was performed using Zeiss LSM 780 or 710 confocal microscopes, Nikon Eclipse 90i or Zeiss Axioimager M2 fluorescence microscopes, or whole-brain STP tomography (detailed below). Imaging from serially mounted sections was performed on a Zeiss LSM 780 or 710 confocal microscope (CSHL St. Giles Advanced Microscopy Center) and Nikon Eclipse 90i fluorescence microscope, using objectives ×63 and ×5 for embryonic tissue, and ×20 for adult tissue, as well as ×5 on a Zeiss Axioimager M2 System equipped with MBF Neurolucida Software (MBF). Quantification and image analysis was performed using Image J/FIJI software. Statistics and plotting of graphs were done using GraphPad Prism 7 and Microsoft Excel 2010.
Twenty-four-hour pulse-chase embryonic experiments
For 24-hour pulse-chase embryonic experiments (Fig. 1, Extended Data Fig. 1), high-magnification insets are not maximum intensity projections. To observe the morphology of RGs, only a few sections from the z-plane in low-magnification images have been projected in the high-magnification images.
Quantification and statistics related to progenitor fate-mapping
Quantification for top panels in Fig. 1h, Extended Data Fig. 2m–o (n = 5–6 from two litters): mean values, number of progenitors ± s.e.m. *P < 0.05 (compared with bin M, RGsLhx2+), #P < 0.05 (compared with bin M, RGsFezf2+), one-way ANOVA, Tukey’s post-hoc test. †P < 0.05 (compared with RGsLhx2+ for corresponding bins), unpaired Student’s t-test. Quantification for bottom panels in Fig. 1h, Extended Data Fig. 2m–o (n = 3 from two litters): mean values for percentage total PyNs (S1) ± s.e.m. *P < 0.05 (compared with PyNsLhx2+). Quantification for Fig. 1k, Extended Data Fig 2t: top panel: (n = 3 from two litters): mean values, number of progenitors ± s.e.m. *P < 0.0001 (compared with RGsLhx2+Fezf2−), unpaired Student’s t-test. Bottom panel (n = 3 from two litters): mean values, number of progenitors ± s.e.m. *P < 0.05 (compared with rostral RGsLhx2+Fezf2−), #P < 0.05 (compared with rostral RGsLhx2+Fezf2+), one-way ANOVA, Tukey’s post-hoc test. †P < 0.05 (compared with RGsLhx2+/Fezf2− for corresponding regions), unpaired Student’s t-test.
Target-specific cell depth measurement
Cell depth analysis for retrogradely labelled projection-specific genetically identified PyNs (GeneX-CreER) were obtained using 5× MBF fluorescent widefield images of 65-µm thick coronal sections in MO and SSp-bfd. MO cell depths are presented in micrometres owing to the absence of a defined white matter border in frontal cortical areas and SSp-bfd depth ratio measurements were normalized to the distance from pia to white matter. For each condition we quantified at least four sections taken from two mice.
Whole-brain STP tomography and image analysis
Perfused and post-fixed brains from adult mice were embedded in oxidized agarose and imaged with TissueCyte 1000 (Tissuevision) as described48,49. We used the whole-brain STP tomography pipeline previously described48,49. Perfused and post-fixed brains from adult mice, prepared as described above, were embedded in 4% oxidized-agarose in 0.05 M PB, cross-linked in 0.2% sodium borohydrate solution (in 0.05 M sodium borate buffer, pH 9.0–9.5).The entire brain was imaged in coronal sections with a 20× Olympus XLUMPLFLN20XW lens (NA 1.0) on a TissueCyte 1000 (Tissuevision) with a Chameleon Ultrafast-2 Ti:Sapphire laser (Coherent). EGFP/EYFP or tdTomato signals were excited at 910 nm or 920 nm, respectively. Whole-brain image sets were acquired as series of 12 (x) × 16 (y) tiles with 1 μm × 1 μm sampling for 230–270 z sections with a 50-μm z-step size. Images were collected by two PMTs (PMT, Hamamatsu, R3896), for signal and autofluorescent background, using a 560-nm dichroic mirror (Chroma, T560LPXR) and band-pass filters (Semrock FF01-680/SP-25). The image tiles were corrected to remove illumination artifacts along the edges and stitched as a grid sequence47,49. Image processing was completed using ImageJ/FIJI and Adobe/Photoshop software with linear level and nonlinear curve adjustments applied only to entire images.
Cell body detection from whole-brain STP data
PyN somata were automatically detected from cell-type specific reporter lines (R26-LSL-GFP or Ai14) by a convolutional network trained as described previously48. Detected PyN soma coordinates were overlaid on a mask for cortical depth, as described48.
Axon detection from whole-brain STP data
For axon projection mapping, PyN axon signal based on cell-type-specific viral expression of EGFP or EYFP was filtered by applying a square root transformation, histogram matching to the original image, and median and Gaussian filtering using Fiji/ImageJ software50 so as to maximize signal detection while minimizing background auto-fluorescence, as described before51. A normalized subtraction of the autofluorescent background channel was applied and the resulting thresholded images were converted to binary maps. Three-dimensional rendering was performed on the basis of binarized axon projections and surfaces were determined based on the binary images using Imaris software (Bitplane). Projections were quantified as the fraction of pixels in each brain structure relative to each whole projection.
Axon projection cartoon diagrams from whole-brain STP data
To generate cartoons of axon projections for a given driver line, axon detection outputs from all individual experiments were compared (sorting the values from high to low), and analysed side-by-side with low-resolution image stacks (and the CCFv3 registered to the low-resolution dataset for brain area definition) to get a general picture of the injection, as well as high-resolution images for specific brain areas.
Registration of whole-brain STP image datasets
Registration of brain-wide datasets to the Allen reference Common Coordinate Framework (CCF) version 3 was performed by 3D affine registration followed by a 3D B-spline registration using Elastix software52, according to established parameters52. For cortical depth and axon projection analysis, we registered the CCFv3 to each dataset so as to report cells detected and pixels from axon segmentation in each brain structure without warping the imaging channel.
In vitro electrophysiology
Brain slice preparation
Mice (>P30) were anaesthetized with isoflurane, decapitated, brains dissected out and rapidly immersed in ice-cold, oxygenated, artificial cerebrospinal fluid (section ACSF: 110 mM choline-Cl, 2.5 mM KCl, 4 mM MgSO4, 1 mM CaCl2, 1.25 mM NaH2PO4, 26 mM NaHCO3, 11 mM d-glucose, 10 mM Na ascorbate, 3.1 Na pyruvate, pH 7.35, 300 mOsm) for 1 min. Coronal cortical slices containing somatomotor cortex were sectioned at a 300-µm thickness using a vibratome (HM 650 V; Microm) at 1–2 °C and incubated with oxygenated ACSF (working ACSF; 124 mM NaCl, 2.5 mM KCl, 2 mM MgSO4, 2 mM CaCl2, 1.25 mM NaH2PO4, 26 mM NaHCO3, 11 mM d-glucose, pH 7.35, 300 mOsm) at 34 °C for 30 min, and subsequently transferred to ACSF at room temperature (25 °C) for more than 30 min before use. Whole-cell patch recordings were directed to the somatosensory and motor cortex, and the subcortical whiter matter and corpus callosum served as primary landmarks according to the atlas (Paxinos and Watson Mouse Brain in Stereotaxic Coordinates, 3rd edition).
Patch-clamp recording in brain slices
Patch pipettes were pulled from borosilicate glass capillaries with filament (1.2 mm outer diameter and 0.69 mm inner diameter; Warner Instruments) with a resistance of 3–6 MΩ. The pipette recording solution consisted of 130 mM potassium gluconate, 15 mM KCl, 10 mM sodium phosphocreatine, 10 mM HEPES, 4 mM ATP·Mg, 0.3 mM GTP and 0.3 mM EGTA (pH 7.3 adjusted with KOH, 300 mOsm). Dual or triple whole-cell recordings from tdTomato+ and EGFP+ PyNs were made with Axopatch 700B amplifiers (Molecular Devices) using an upright microscope (Olympus, BX51) equipped with infrared-differential interference contrast optics (IR-DIC) and a fluorescence excitation source. Both IR-DIC and fluorescence images were captured with a digital camera (Microfire, Optronics). All recordings were performed at 33–34 °C with the chamber perfused with oxygenated working ACSF.
Recordings were made with two MultiClamp 700B amplifiers (Molecular Devices). The membrane potential was maintained at −75 mV in the voltage clamping mode and zero holding current in the current clamping mode, without the correction of junction potential. Signals were recorded and filtered at 2 kHz, digitalized at 20 kHz (DIGIDATA 1322A, Molecular Devices) and further analysed using the pClamp 10.3 software (Molecular Devices) for intrinsic properties.
Further information on research design is available in the Nature Research Reporting Summary linked to this paper.
Raw and stitched whole-brain STP imaging data are available from the BICCN Brain Image Library (BIL) (http://www.brainimagelibrary.org/download.html) at the Pittsburgh Supercomputing Center. Anterograde projection and cell distribution datasets can be visualized on the Mouse Brain architecture website (http://brainarchitecture.org/cell-type/projection and http://brainarchitecture.org/cell-type/density, respectively) as detailed in Supplementary Tables 4, 5.
Harris, K. D. & Shepherd, G. M. The neocortical circuit: themes and variations. Nat. Neurosci. 18, 170–181 (2015).
Huang, Z. J. Toward a genetic dissection of cortical circuits in the mouse. Neuron 83, 1284–1302 (2014).
Greig, L. C., Woodworth, M. B., Galazo, M. J., Padmanabhan, H. & Macklis, J. D. Molecular logic of neocortical projection neuron specification, development and diversity. Nat. Rev. Neurosci. 14, 755–769 (2013).
Lodato, S. & Arlotta, P. Generating neuronal diversity in the mammalian cerebral cortex. Annu. Rev. Cell Dev. Biol. 31, 699–720 (2015).
Kawaguchi, Y. Pyramidal cell subtypes and their synaptic connections in layer 5 of rat frontal cortex. Cereb. Cortex 27, 5755–5771 (2017).
Tasic, B. et al. Shared and distinct transcriptomic cell types across neocortical areas. Nature 563, 72–78 (2018).
Rakic, P. The radial edifice of cortical architecture: from neuronal silhouettes to genetic engineering. Brain Res. Rev. 55, 204–219 (2007).
Kriegstein, A., Noctor, S. & Martínez-Cerdeño, V. Patterns of neural stem and progenitor cell division may underlie evolutionary cortical expansion. Nat. Rev. Neurosci. 7, 883–890 (2006).
Telley, L. et al. Temporal patterning of apical progenitors and their daughter neurons in the developing neocortex. Science 364, aav2522 (2019).
Arlotta, P. et al. Neuronal subtype-specific genes that control corticospinal motor neuron development in vivo. Neuron 45, 207–221 (2005).
Molyneaux, B. J., Arlotta, P., Hirata, T., Hibi, M. & Macklis, J. D. Fezl is required for the birth and specification of corticospinal motor neurons. Neuron 47, 817–831 (2005).
Muralidharan, B. et al. LHX2 interacts with the NuRD complex and regulates cortical neuron subtype determinants Fezf2 and Sox11. J. Neurosci. 37, 194–203 (2017).
He, M. et al. Strategies and tools for combinatorial targeting of GABAergic neurons in mouse cerebral cortex. Neuron 91, 1228–1243 (2016).
Florio, M. & Huttner, W. B. Neural progenitors, neurogenesis and the evolution of the neocortex. Development 141, 2182–2194 (2014).
Martínez-Cerdeño, V. et al. Evolutionary origin of Tbr2-expressing precursor cells and the subventricular zone in the developing cortex. J. Comp. Neurol. 524, 433–447 (2016).
Kowalczyk, T. et al. Intermediate neuronal progenitors (basal progenitors) produce pyramidal-projection neurons for all layers of cerebral cortex. Cereb. Cortex 19, 2439–2450 (2009).
Vasistha, N. A. et al. Cortical and clonal contribution of Tbr2 expressing progenitors in the developing mouse brain. Cereb. Cortex 25, 3290–3302 (2015).
Englund, C. et al. Pax6, Tbr2, and Tbr1 are expressed sequentially by radial glia, intermediate progenitor cells, and postmitotic neurons in developing neocortex. J. Neurosci. 25, 247–251 (2005).
Hintiryan, H. et al. The mouse cortico-striatal projectome. Nat. Neurosci. 19, 1100–1114 (2016).
Hooks, B. M. et al. Topographic precision in sensory and motor corticostriatal projections varies across cell type and cortical area. Nat. Commun. 9, 3549 (2018).
Zingg, B. et al. Neural networks of the mouse neocortex. Cell 156, 1096–1111 (2014).
Nieto, M. et al. Expression of Cux-1 and Cux-2 in the subventricular zone and upper layers II–IV of the cerebral cortex. J. Comp. Neurol. 479, 168–180 (2004).
Weiss, L. A. & Nieto, M. The crux of Cux genes in neuronal function and plasticity. Brain Res. 1705, 32–42 (2019).
Harris, J. A. et al. Anatomical characterization of Cre driver mice for neural circuit mapping and manipulation. Front. Neural Circuits 8, 76 (2014).
Chauvet, S. et al. Gating of Sema3E/PlexinD1 signaling by neuropilin-1 switches axonal repulsion to attraction during brain development. Neuron 56, 807–822 (2007).
Ding, J. B., Oh, W. J., Sabatini, B. L. & Gu, C. Semaphorin 3E–Plexin-D1 signaling controls pathway-specific synapse formation in the striatum. Nat. Neurosci. 15, 215–223 (2011).
Leone, D. P., Srinivasan, K., Chen, B., Alcamo, E. & McConnell, S. K. The determination of projection neuron identity in the developing cerebral cortex. Curr. Opin. Neurobiol. 18, 28–35 (2008).
Pecho-Vrieseling, E., Sigrist, M., Yoshida, Y., Jessell, T. M. & Arber, S. Specificity of sensory-motor connections encoded by Sema3e–Plxnd1 recognition. Nature 459, 842–846 (2009).
Han, W. et al. TBR1 directly represses Fezf2 to control the laminar origin and development of the corticospinal tract. Proc. Natl Acad. Sci. USA 108, 3041–3046 (2011).
Galazo, M. J., Emsley, J. G. & Macklis, J. D. Corticothalamic projection neuron development beyond subtype specification: Fog2 and intersectional controls regulate intraclass neuronal diversity. Neuron 91, 90–106 (2016).
Koop, K. E., MacDonald, L. M. & Lobe, C. G. Transcripts of Grg4, a murine groucho-related gene, are detected in adjacent tissues to other murine neurogenic gene homologues during embryonic development. Mech. Dev. 59, 73–87 (1996).
Molyneaux, B. J. et al. DeCoN: genome-wide analysis of in vivo transcriptional dynamics during pyramidal neuron fate selection in neocortex. Neuron 85, 275–288 (2015).
Chang, M., Suzuki, N. & Kawai, H. D. Laminar specific gene expression reveals differences in postnatal laminar maturation in mouse auditory, visual, and somatosensory cortex. J. Comp. Neurol. 526, 2257–2284 (2018).
Ferland, R. J., Cherry, T. J., Preware, P. O., Morrisey, E. E. & Walsh, C. A. Characterization of Foxp2 and Foxp1 mRNA and protein in the developing and mature brain. J. Comp. Neurol. 460, 266–279 (2003).
Kast, R. J., Lanjewar, A. L., Smith, C. D. & Levitt, P. FOXP2 exhibits projection neuron class specific expression, but is not required for multiple aspects of cortical histogenesis. Elife 8, e42012 (2019).
Rousso, D. L. et al. Two pairs of ON and OFF retinal ganglion cells are defined by intersectional patterns of transcription factor expression. Cell Rep. 15, 1930–1944 (2016).
Economo, M. N. et al. Distinct descending motor cortex pathways and their roles in movement. Nature 563, 79–84 (2018).
Daigle, T. L. et al. A Suite of transgenic driver and reporter mouse lines with enhanced brain-cell-type targeting and functionality. Cell 174, 465–480 (2018).
Gerfen, C. R., Paletzki, R. & Heintz, N. GENSAT BAC Cre-recombinase driver lines to study the functional organization of cerebral cortical and basal ganglia circuits. Neuron 80, 1368–1383 (2013).
Peng, H. et al. Morphological diversity of single neurons in molecularly defined cell types. Nature https://doi.org/10.1038/s41586-021-03941-1 (2021).
Wang, X. et al. Genetic single neuron anatomy reveals fine granularity of cortical axo-axonic cells. Cell Rep. 26, 3145–3159 (2019).
Winnubst, J. et al. Reconstruction of 1,000 projection neurons reveals new cell types and organization of long-range connectivity in the mouse brain. Cell 179, 268–281 (2019).
Blankvoort, S., Witter, M. P., Noonan, J., Cotney, J. & Kentros, C. Marked diversity of unique cortical enhancers enables neuron-specific tools by enhancer-driven gene expression. Curr. Biol. 28, 2103–2114 (2018).
Hodge, R. D. et al. Conserved cell types with divergent features in human versus mouse cortex. Nature 573, 61–68 (2019).
Taniguchi, H. et al. A resource of Cre driver lines for genetic targeting of GABAergic neurons in cerebral cortex. Neuron 71, 995–1013 (2011).
Tervo, D. G. et al. A designer AAV variant permits efficient retrograde access to projection neurons. Neuron 92, 372–382 (2016).
Preibisch, S., Saalfeld, S. & Tomancak, P. Globally optimal stitching of tiled 3D microscopic image acquisitions. Bioinformatics 25, 1463–1465 (2009).
Kim, Y. et al. Brain-wide maps reveal stereotyped cell-type-based cortical architecture and subcortical sexual dimorphism. Cell 171, 456–469 (2017).
Ragan, T. et al. Serial two-photon tomography for automated ex vivo mouse brain imaging. Nat. Methods 9, 255–258 (2012).
Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676–682 (2012).
Mandelbaum, G. et al. Distinct cortical-thalamic-striatal circuits through the parafascicular nucleus. Neuron 102, 636–652 (2019).
Klein, S., Staring, M., Murphy, K., Viergever, M. A. & Pluim, J. P. elastix: a toolbox for intensity-based medical image registration. IEEE Trans. Med. Imaging 29, 196–205 (2010).
Bulchand, S., Grove, E. A., Porter, F. D. & Tole, S. LIM-homeodomain gene Lhx2 regulates the formation of the cortical hem. Mech. Dev. 100, 165–175 (2001).
Mangale, V. S. et al. Lhx2 selector activity specifies cortical identity and suppresses hippocampal organizer fate. Science 319, 304–309 (2008).
Monuki, E. S., Porter, F. D. & Walsh, C. A. Patterning of the dorsal telencephalon and cerebral cortex by a roof plate–Lhx2 pathway. Neuron 32, 591–604 (2001).
Shetty, A. S. et al. Lhx2 regulates a cortex-specific mechanism for barrel formation. Proc. Natl Acad. Sci. USA 110, E4913–E4921 (2013).
Woodworth, M. B., Greig, L. C., Kriegstein, A. R. & Macklis, J. D. SnapShot: cortical development. Cell 151, 918–918 (2012).
Martínez-Cerdeño, V., Noctor, S. C. & Kriegstein, A. R. The role of intermediate progenitor cells in the evolutionary expansion of the cerebral cortex. Cereb. Cortex 16, i152–i161 (2006).
Cubelos, B., Briz, C. G., Esteban–Ortega, G. M. & Nieto, M. Cux1 and Cux2 selectively target basal and apical dendritic compartments of layer II–III cortical neurons. Dev. Neurobiol. 75, 163–172 (2015).
Cubelos, B. et al. Cux1 and Cux2 regulate dendritic branching, spine morphology, and synapses of the upper layer neurons of the cortex. Neuron 66, 523–535 (2010).
Rodriguez–Tornos, F. M. et al. Cux1 enables interhemispheric connections of layer II/III neurons by regulating kv1–dependent firing. Neuron 89, 494–506 (2016).
Lodato, S. et al. Gene co-regulation by Fezf2 selects neurotransmitter identity and connectivity of corticospinal neurons. Nat. Neurosci. 17, 1046–1054 (2014).
Di Bella, D. J. et al. Molecular logic of cellular diversification in the mammalian cerebral cortex. Nature 595, 554–559 (2021).
Oh, W. J. & Gu, C. The role and mechanism-of-action of Sema3E and Plexin-D1 in vascular and neural development. Semin. Cell Dev. Biol. 24, 156–162 (2013).
Watakabe, A., Ohsawa, S., Hashikawa, T. & Yamamori, T. Binding and complementary expression patterns of semaphorin 3E and plexin D1 in the mature neocortices of mice and monkeys. J. Comp. Neurol. 499, 258–273 (2006).
Mihalas, A. B. & Hevner, R. F. Control of neuronal development by T-box genes in the brain. Curr. Top. Dev. Biol. 122, 279–312 (2017).
Sorensen, S. A. et al. Correlated gene expression and target specificity demonstrate excitatory projection neuron diversity. Cereb. Cortex 25, 433–449 (2015).
Kinare, V. et al. An evolutionarily conserved Lhx2–Ldb1 interaction regulates the acquisition of hippocampal cell fate and regional identity. Development 147, dev187856 (2020).
Godbole, G. et al. Hierarchical genetic interactions between FOXG1 and LHX2 regulate the formation of the cortical hem in the developing telencephalon. Development 145, dev154583 (2018).
Eckler, M. J. et al. Fezf1 and Fezf2 are required for olfactory development and sensory neuron identity. J. Comp. Neurol. 519, 1829–1846 (2011).
Eckler, M. J. et al. Multiple conserved regulatory domains promote Fezf2 expression in the developing cerebral cortex. Neural Dev. 9, 6 (2014).
We thank R. Palmiter for providing the FoxP2-IRES-Cre mouse line; Y. Yoshida for providing the Sema3E-CreER mouse line; L. Li at CSHL for help with generation of knock-in mice; S. M. Kelly for contributing to the generation and characterization of the Tis21-2A-CreER mouse line; Y. Kim for providing the digital flatmap of the mouse cortex; F. Boato for help in mouse breeding and brain tissue preparation; K. Kelly for project management; H. Kondo for providing anatomical datasets; S. Srivas for help with Tbr1 driver data; and B. Huo, X. Li, F. Xu and K. Ram for depositing data to the repository and administering and uploading data to the Brain Architecture portal. We thank CSHL Animal Resources for mouse husbandry. This work was supported in part by the NIH grants 5R01MH101268-05 and 5U19MH114821-03 to Z.J.H. and P.A.; 1S10OD021759-01 to Z.J.H.; and the CSHL Robertson Neuroscience Fund to Z.J.H. P.O. is supported by NIH U01 MH114824-01. D.H. was supported by the Human Frontier Science Program long-term fellowship LT000075/2014-L and NARSAD Young Investigator grant no. 26327. R.R. was supported by the NRSA F31 Predoctoral Fellowship 5F31MH114529-03. J.T. and J.L. were supported by the NRSA F30 Medical Scientist Predoctoral Fellowships 5F30MH097425-03 and 5F30MH108333.
J.A.H. is currently employed by Cajal Neuroscience. The remaining authors declare no competing interests.
Peer review information Nature thanks the anonymous reviewers for their contribution to the peer review of this work. Peer reviewer reports are available.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Extended data figures and tables
a, 24-hour pulse-chase in a E10.5 Lhx2-CreER;Ai14 embryo densely labelled RGsLhx2+ throughout the dorsal neuroepithelium, sharply ending at the cortex–hem boundary (Hm); magnified view shows RGs at different stages of the cell cycle, with endfeet (arrow) or dividing somata (arrowhead) at the ventricle wall (dashed lines). b, E10.5 RGs generate PyNs across layers in P30 neocortex in Lhx2-CreER;RGBow mouse13 (Supplementary Table 1). c, d are duplicated from Fig. 1c, d for comparison. e, Same experiment as in a done at E13.5. RGsLhx2+remain distributed in a medialhigh-laterallow gradient along the dorsal pallium but at a reduced density compared to earlier stages. f, E14.5 RGsLhx2+generated PyNs with lower density in L5/6, higher density in L2-4, and highest density in L4, suggesting more restricted fate potential. g, 24-hour pulse-chase in a E10.5 Fezf2-CreER;Ai14 embryo. The spatial extent of RGsFezf2+ in neuroepithelium is more restricted compared to RGsLhx2+ at this stage; magnified view shows RG endfoot (arrow) at the ventricle (dashed lines). Note the sparsity of dividing RGs. h, Fate-mapping of E10.5 RGsFezf2+ in a Fezf2-CreER;RGBow mouse labelled PyN progeny across all cortical layers. i, j are duplicated from Fig. 1e, f for comparison. k, Same experiment as in g done at E13.5. Only sparse RGsFezf2+ remain in medial pallium at this time, when Fezf2expression shifts to postmitotic PyNs (arrowheads); magnified view shows a remaining RG (arrow) at the ventricle wall (dashed line). l, Fate-mapping at E18.5 in Fezf2-CreER;RGBow labelled only L5b/L6 PyNs in mature cortex. m, Upper panel, quantification of E10.5 RGsLhx2+(red) (in a) versus RGsFezf2+ (pink) (in g) distributed across the cortical primordium, divided into medial (M), dorsal (D) and lateral (L) bins of equal length. Lower panel, laminar distribution of PyNs generated by RGsLhx2+ (red) or RGsFezf2+(pink) at E10.5, shown as percentage of total PyNs in S1 barrel cortex. n, Same quantification of RGsLhx2+ and RGsFezf2+as in m except done at E12.5. o, Same quantification of RGsLhx2+ and RGsFezf2+as in m except done at E13.5 (upper panel), and the laminar distribution of their PyN progeny fate-mapped at E14.5 (for RGsLhx2+) and E18.5 (for RGsFezf2+) (lower panel). p, Fate-mapping E12.5 RGsLhx2+ to mature cortex labelled PyN progeny that are SATB2+ (IT class, 66.8%) as well as SATB2- (non-IT class, 33.2%). Of these, 72.8% of L2-4 (UL; 728 of 1,000 cells) and 60.8% of L5-6 (DL; 304 of 500 cells; n=3 brains from 2 litters) PyNs are of IT-type. q, P5 tamoxifen induction in Lhx2-CreER;Ai14 shows dense labelling of L2-4 PyNs and sparse labelling in L5/6 in P28 cortex (Left panel) Most labelled PyNs are of the IT class expressing SATB2 (middle and right panels; UL, 92.4% - 924 of 1,000 cells; DL, 90.5%–181 of 200 cells; n=3 brains from 2 litters). r, P15 tamoxifen induction in Lhx2-CreER;Ai14. (Upper) Quantification in SSp-bfd shows 58% cells are glia (Mean values for number of cells in SSp-bfd ± SEM. *P < 0.05 compared to PyN number, unpaired Student’s t-test). (Lower) Labelled PyNs are distributed across cortical layers with more labelling in L5a and L4 (n=3 brains from 2 litters). s, Presence of RGsLhx2+Fezf2− (RFP) and RGsLhx2+Fezf2+(EGFP) at E11.5 throughout cortical primordium revealed by intersection/subtraction fate-mapping with 24-hour pulse-chase in Lhx2-CreER;Fezf2-Flp;IS mice, schematized in Fig. 1i (Also see Fig. 1j–n). These progenitors distribute in a medial high-lateral low gradient along the dorsal neuroepithelium, ending at the cortex–hem boundary (Hm). Rostral, Mid and Caudal sectioning levels show a caudal high-rostral low distribution of RGsLhx2+Fezf2− and RGsLhx2+Fezf2+. s’, Magnified view shows RGsLhx2+Fezf2− and RGsLhx2+Fezf2+ at multiple cell cycle stages with endfeet (arrow) and dividing soma (arrowhead) at ventricle wall (dashed line). t, Upper, total number of RGsLhx2+Fezf2+ (green) is approximately half that of RGsLhx2+Fezf2− (red). Lower, quantification of RGsLhx2+Fezf2− versus RGsLhx2+Fezf2+ at rostral (R), mid-level (M) and caudal (C) sections revealed their caudalhigh-rostrallow distribution. Scale bars: 20µm (high magnification) in a, c, e, g, i, k, s’; 100µm for all other panels.
Extended Data Fig. 2 Lhx2 and Fezf2 driver lines precisely recapitulate endogenous developmental expression patterns.
a, Anti-LHX2 immunohistochemistry on a 24-hour pulse-chase in a E12.5 Lhx2-CreER;Ai14 embryo revealed that 99.2% RGsLhx2+ express LHX2 (1410 of 1422 cells; n = 4 embryos from 2 litters). High magnification images show colocalization (arrowheads). Note the medialhigh-laterallow gradient. b, 24-hour pulse-chase in a E10.5 Lhx2-CreER;Ai14embryo densely labelled RGs throughout the dorsal neuroepithelium, ending medially at the cortex–hem boundary (Hm). This expression recapitulated Lhx2 mRNA in-situ hybridization at E10.5 (reproduced/adapted with permission from Development)68. c, Same experiment as in b done at E12.5. The medialhigh-laterallow gradient of RGsLhx2+ is highly similar to Lhx2 mRNA expression (reproduced/adapted with permission from Development)69. d, Same experiment as in b done at E13.5. Note the reduction in RGsLhx2+ and concomitant increase in post-mitotic cells (arrowheads), in both the Lhx2 driver line and mRNA expression (ISH Data: Allen Brain Atlas: Developing Mouse Brain). e, anti-LHX2 immunohistochemistry on a 24-hour pulse-chase in a E12.5 Fezf2-CreER;Ai14 embryo reveals that 89.7% RGsFezf2+express LHX2 (376 of 419 cells; n =4 embryos from 2 litters); high magnification images show colocalization (arrowheads) and non-colocalization (arrow and encircled). f, 24-hour pulse-chase in a E10.5 Fezf2-CreER;Ai14 embryo. The spatial extent of RGsFef2+ is restricted compared to RGsLhx2+ at this stage. This sparse labelling recapitulated Fezf2 mRNA expression at E10.5 (reproduced/adapted with permission from J Comp Neurol)70. g, Same experiment as in f done at E12.5. The medialhigh-laterallow distribution gradient of RGsFezf2+ is also seen with Fezf2 expression at this stage. Note RGsFezf2+ are sparsely labelled compared to RGsLhx2+using in-situ hybridization at E12.5 (reproduced/adapted via Open Access from Neural Dev)71. h, Same experiment as in f done at E13.5. The drastic decrease of Fezf2expression in RGsFezf2+ accompanied by an increase in post-mitotic PyNs (arrowheads) is comparable in both Fezf2-CreER; Ai14 and Fezf2 in-situ data (ISH Data: Allen Brain Atlas: Developing Mouse Brain). i, anti-LHX2 immunohistochemistry on E13 Fezf2-FlpO;FSF-tdTomato embryo reveals that 91.7% RGsFezf2+ express LHX2 (718 of 783 cells; n = 4 embryos from 2 litters). Similar to e. high magnification images show colocalization (arrowheads) and non-colocalization (asterisk). Note the medialhigh-laterallow gradient. Scale bars for low mag images = 100µm in a-i. Scale bars for high mag images = 20µm in a, e, i.
a, Fate-mapping strategy for intermediate progenitors (IPs) and indirect neurogenesis, used in c-e. Tbr2-CreER labels an IP and all of its progeny with a fluorescent marker when combined with Ai14 (Left). The intersection of Tis21-CreER and Tbr2-FlpER specifically targets neurogenic IPs when combined with the Ai65 intersectional reporter (Right). b, Simultaneous fate-mapping of different molecularly defined neurogenic RGs using an intersection/subtraction reporter (IS) combined with Tis21-CreER and Fezf2-Flp drivers. This scheme is used in h-k. In RGsTis21+Fezf2−, Cre activates RFP expression only. In RGsTis21+Fezf2+, Cre and Flp recombinations remove the RFP cassette and activate EGFP expression. At a later stage when Fezf2 is only expressed in postmitotic deep layer PyNs, Tis21-CreER in RGs activates RFP expression in all of its progeny, but RFP is then switched to EGFP only in Fezf2+ PyNs expressing Flp. c, E16.5 IPs densely labelled by 12-hour pulse-chase in Tbr2-CreER;Ai14 mice; magnified view shows IP somata (arrowhead) away from the lateral ventricle (dashed line) lacking radial fibers and endfeet. d, Fate-mapping E16.5 IPs in Tbr2-CreER;Ai14mice labels PyNs in L2-3 cortex at P28. e, Intersectional fate-mapping of neurogenic IPs at E16.5 in Tis21-CreER;Tbr2-FlpER;Ai65 mice, as depicted in a, labelled L2-3 PyN progeny in P28 cortex. f, 48-hr pulse-chase in E10.5 Tis21-CreER;Ai14 embryo labels Tis21+ neurogenic progenitors (nRGs) and their postmitotic progeny throughout the neural tube, including dorsal pallium (high magnification). Self-renewing RGs are identified by their endfeet at the ventricular surface (arrowheads) and radial fibers (arrow). g, Fate-mapping of E10.5 nRGs to mature cortex reveals PyNs are distributed throughout cortical layers. Note that multipolar GABAergic interneurons (some in layer 1) derived from subpallium nRGs are also labelled (arrowheads). h, The presence of nRGsFezf2− and nRGsFezf2+ at E11.5 is revealed by intersection/subtraction fate-mapping with 24-hour pulse-chase in Tis21-CreER;Fezf2-Flp;IS mice, schematized in b; magnified view shows RFP-labelled nRGsFezf2− and EGFP-labelled nRGsFezf2+. i, Fate-mapping E11.5 nRGs using Tis21-CreER;Fezf2-Flp;IS mice. The mixed RFP and EGFP clone is likely to have derived from a nRGFezf2−, which activated RFP expression in all progeny and EGFP expression was then switched on only in Fezf2+ postmitotic deep layer PyNs expressing Flp. j, k, More examples of differential fate-mapping of nRGsFezf2− and nRGsFezf2+ from E12.5 to the mature cortex using the scheme in b. The majority of clones consist of mixed RFP and EGFP PyNs (j’), and rarely RFP-only (j”) or EGFP-only PyNs (k). RFP-only clones (1 of 29) probably derive from nRGFezf2− whose progeny were all Fezf2− (j”). EGFP-only clones (2 of 29) are derived from nRGsFezf2+, suggesting multipotency of RGsFezf2+ (k). Mixed RFP/EGFP clones are most prominent and are likely to result from Cre activation of RFP in nRGsFezf2− and subsequent Flp activation of EGFP in Fezf2+ L5/6 postmitotic PyNs (i,j’). Scale bars: 500µm in d, j, k; 100µm in d (high mag), e, f, g, h, i, j’,j”, k (high mag); 20µm in c, e, h.
Extended Data Fig. 4 Comparison of new with existing driver lines in terms of areal and laminar patterns.
a, Side-by-side comparison of Cre recombination patterns from 8 mouse driver lines characterized in this study (blue font) and 4 existing driver lines (black font) visualized through reporter expression (green; background autofluorescence in red), grouped according to IT, PT and CT projection classes. First row: coronal hemisections at Bregma -1.7 mm. Second row: Image panel showing cortical depth detailing cell body distribution pattern of PyN subpopulations within SSp-bfd taken from the hemisection above at level Bregma -1.7 mm. Third row: coronal hemisections at Bregma 0 mm. Image panel showing cortical depth detailing cell body distribution pattern of PyN subpopulations within MOp taken from the hemisection above at level Bregma 0 mm. For comparison to the PT driver Sim1-Cre transgenic line, see reference 37. b, Cortex-wide distribution patterns of PyN subpopulations viewed as cortical flatmaps in a side-by-side comparison of 8 newly generated (blue font) and 4 existing driver lines (black font): first row, normalized for each dataset’s total number of cells detected; second row, absolute scale per flatmap grid area, with maximum number of cells for any PyN subpopulation. Arrowheads indicate gaps in expression and labelling. b’ shows cortical flat-mapping coordinate space and two exemplary coronal hemisections describing the demarcations used to generate the cortical grid for flatmapping48. c, Overview of brain-wide cell body distribution patterns for each driver line. This table provides an overall impression of the recombination patterns in major adult brain regions in selected lines. d, Histograms showing normalized laminar distribution for six genetically targeted PyN subpopulations by cortical area. Brain-wide cortical depth quantification was performed based on cell detection by convolutional networks from GeneX-CreER driver lines crossed to Ai14 (R26-LSL-tdTomato), R26-LSL-h2b-GFP or Snap25-LSL-EGFP reporters and induced at the ages specified in Fig. 2, and P7 for Sema3E. The normalized cortical depth (0-1) was divided into 24 bins for the left histogram and 124 bins for the right plot in each panel. Abbreviations explained in the Supplementary Information. Scale bars: Last panel of first and third rows applies to all hemisections, 1mm; last panel of second and fourth rows applies to all cortical depth image panels, 200µm.
Extended Data Fig. 5 Comparison of new with existing driver lines in terms of axon projections from SSp-bfd somatosensory cortex.
a-c, STP images at the SSp injection site (first row, arrow head) and at selected subcortical projection targets for eight driver lines characterized in this study (coloured gene names code for IT-red, PT-blue and CT-purple) compared to seven existing driver lines (black gene names), with EGFP or EYFP expression from Cre-activated viral vector (green) and background autofluorescence (red). Arrows point to axons. a, IT drivers project to cortical and striatal targets. PyNsPlxnd1 project bilaterally to cortex and striatum; PyNsCux1 project bilaterally to cortex but not to striatum. b, PT drivers project to many corticofugal targets including brainstem and spinal cord. PyNsFezf2, PyNsAdcyap1 and PyNsTcerg1l project to multiple ipsilateral targets and to the contralateral brainstem (arrows). c, CT drivers project predominantly to the thalamus. PyNsTbr1 project bilaterally to cortex and to ipsilateral thalamus, PyNsFoxp2 and PyNsTle4 project to the ipsilateral cortex and thalamus. Scale bars: first row in c (applies to first row), 1 mm; second to eighth rows in c (applies to each respective row), 200 µm; CST panel (bottom row) in c applies to entire row, 100 µm. Asterisks in b & c indicate presence of passing fibers. A side-by-side list of axon projection matrix for all these lines is presented in Fig. 3d.
a, d, Low magnification images of sections of somatosensory cortex (SSp) at P7 stained with antibodies against CTIP2, CUX1, and tdTomato from PyN-CreER;Ai14 mice induced with tamoxifen. Inset to the right shows markers and Tomato+cell distributions across layers. Fezf2-, Tcerg1l-, Adcyap1- and Tle4-CreER;Ai14 were induced at E16.5 and collected at P7. Tbr1-, Cux1- and Plxnd1-CreER;Ai14 were induced at P4 and collected at P7. Tbr2-CreER;Ai14 was induced at E16.5 (not shown) or E17.5 and collected at P7. Lhx2-CreER;Ai14 was induced at P3 and collected at P7. a’, d’, Histograms showing radial distribution of Tomato+ cells in the cortical plate, in the region corresponding to SSp. In brief, in CUX1- and CTIP2-stained sections, Tomato+ cell depths relative to the thickness of the cortex were measured, as well as the limits of the areas occupied by CUX1+ or CTIP2HIGH cells, shown in green (layers 2-4) and blue (layer 5b) bars, respectively (average relative values for the same sections, gray shading corresponds to 1 SD). For Tbr2-CreER;Ai14, mice induced at E16.5 or E17.5 were quantified separately, showing the later induction (darker red) results in more superficial labelling. Quantifications were made from 4-10 sections from 2-3 different mice for each line. b, e, Magnification of Tomato+ cells in sections co-stained against CUX1 and CTIP2, LDB2 (enriched in PT), FOG2 (expressed in CT), BRN2, or SATB2 (expressed in IT). Arrowheads show double-positive cells; asterisks show Tomato+ cells not expressing the marker. c, f, Percentage of Tomato+ cells stained with each antibody. Quantifications were done in equivalent areas (320µm by 320µm) within the SSp centered in the specified layers. Each dot is an area from a different section, for which the percentage of double positive cells was calculated. Bars are mean+SD. Quantifications were made from 4-8 sections from 2-3 different mice for each line. Tbr2-CreER;Ai14 labelled CUX1+, SATB2+, BRN2+ IT in the most superficial layers 2-3, irrespective of their induction time. Lhx2-CreER;Ai14 and Cux1-CreER;Ai14 labelled CUX1+, SATB2+, BRN2+ IT deeper in layers 2-3. Plxnd1-CreER;Ai14 labelled SATB2+, BRN2+cells in layer 5A, as well as CUX1+, SATB2+, BRN2+ cells in layer 4. No cells were found in layer 5B. Tcerg1l-CreER;Ai14 and Adcyap1-CreER;Ai14 labelled sparse LDB2+, CTIP2+ PT in layer 5. Fezf2-CreER;Ai14 extensively labelled PT in layer 5 that were LDB2+, CTIP2+, as well as some CT in layer 6 expressing CTIP2 and FOG2. Tle4-CreER;Ai14 and Tbr1-CreER;Ai14 labelled CT expressing FOG2 and CTIP2 (and lower levels of LDB2) in layer 6. Tle4-CreER;Ai14 also labelled some LDB2+, CTIP2+ cells in layer 5 (PT), whereas Tbr1-CreER;Ai14 also labelled some CUX1+, BRN2+ IT in layer 2/3. g, Fate-mapping of PyNsTbr1 using Tbr1-CreER; Ai14 mice. Tamoxifen induction at E14.5 densely labelled L6 CT cells with minor labelling of cells in layers 3-5. h, Tamoxifen induction at E15.5 labelled L6 CT cells. i, Tamoxifen induction at P4 labelled L6 CT cells and also a subset of L2/3 cells. A subset of adult PyNsTbr1 labelled from E14.5, E15.5 and P4 induction project to contralateral cortex via the corpus callosum (arrowheads, g’, h’, i’). Scale bars: g-i, low magnification, 500µm; high magnification, 100µm.
Extended Data Fig. 7 Anterograde tracing, registration to CCFv3 and analysis of PyN projections from SSp-bfd.
a, Summary table of driver lines and viral vectors used for anterograde tracing from PyNs in primary somatosensory cortex, related to Fig. 3. b, Virus injection centroid coordinates across single driver experiments in CCFv3 space on a dorsal whole-brain view. c-e, Whole-brain 3D renderings of axon projections registered to CCFv3 and main projection targets for each PyN subpopulation in the SSp-bfd. f, Axon projection matrix from SSp-bfd to 321 ipsilateral and 321contralateral targets (in columns), each grouped under 12 major categories (top row) for each of the driver lines generated in this study highlighted in Fig. 3, and presented alongside several previously published driver lines (IT lines: Cux2, Sepw1, Rasgrf2, Tlx3; PT lines: Rbp4, Sim1; CT lines: Ntsr1) for comparison (see Extended Data Fig. 5 for images). Colour shades in each row represent fraction of total axon signal measured from a single experiment per brain area; signal in the inj. site (white) was subtracted from total axon signal to show the fraction of projections outside the inj. site. PyNsPlxnd1 project bilaterally to CTX and Str; PyNsCux1 project bilaterally to CTX but minimally to Str; PyNsFezf2, PyNsAdcyap1 and PyNsTcerg1l project to multiple ipsilateral targets, and contralateral brainstem (arrows); PyNsTbr1 project bilaterally to CTX and ipsilaterally to thalamus, PyNsFoxp2 and PyNsTle4 project to the ipsilateral CTX and thalamus. Scale bar in d (for all 3D renderings in c-e), 2 mm. Asterisks in f indicate passing fibers. Abbreviations explained in the Supplementary Information.
Extended Data Fig. 8 Anterograde tracing of axon projections from one or two PyN populations using single- or double-allele driver mice, respectively.
a, 3D rendering from STP imaging of PyNsSema3E projection pattern based on injection of AAV9-Ef1a-DIO-ChR2-EYFP followed by tamoxifen induction (2 days post-injection): dorsal view (left) and parasagittal view (right). b, Coronal section containing injection site in a Sema3E-CreER;Ai14 mouse. c, PyNsSema3E project via the cerebral peduncle (cp) to the pons (Pn). PyNsSema3E infected with AAV9-Ef1a-DIO-ChR2-EYFP express EYFP/tdTomato; all other PyNsSema3Eexpress tdTomato by tamoxifen induction. d, PyNsSema3E at injection site, showing somata in layer 5 with slender tufted apical dendrites. e, PyNsSema3E axons in thalamus with large boutons in POm (e’). f-r, Simultaneous anterograde tracing from two driver allele-defined PyN populations. f, Schematic showing simultaneous anterograde tracing from PyNs targeted by Fezf2-Flp (green) and Tle4-CreER (red) with co-injection of Flp- and Cre- dependent AAVs expressing EGFP and mCherry, respectively (g-l). g, PyNsFezf2 and PyNsTle4 at the injection site occupying mainly L5B and L6, respectively. h, PyNFezf2 and PyNTle4 projection patterns converge in primary thalamus, VPM, whereas PyNsFezf2 collaterals (asterisk) extend medially to higher order thalamic nuclei. i, PyNsFezf2 (green) extend axon collaterals in Str, whereas PyNsTle4 (red) pass through en route to thalamus. j-l, PyNsFezf2 but not PyNsTle4 project to multiple other corticofugal targets, including SC, Pn and cSp5. m, Schematic showing simultaneous anterograde tracing from PyNs targeted by Plxnd1-Flp (green) and Fezf2-CreER (red) with co-injection of Flp- and Cre-dependent AAVs expressing EGFP and mCherry, respectively (n-r). n, PyNsPlxnd1 and PyNsFezf2 at the injection site in motor cortex occupying mainly L5A and L5B/L6, respectively. o-p, PyNsFezf2 but not PyNsPlxnd1 project to Thal (o) and medulla (p). q-r, PyNsPlxnd1 and PyNsFezf2 project to ipsilateral Str with overlapping terminals (r), whereas PyNsPlxnd1 but not PyNsFezf2 project to contralateral Str (q). Asterisks indicate PyNFezf2 collaterals and arrows indicate PyNPlxnd1 collaterals. Scale bars: a, 2 mm; b, 1 mm; c-e, 200 µm; e’, 100µm; l (applies to g-l), 200µm; n-r, 200µm; q’ & r’, 100µm.
a, Strategy for retrograde labelling of PyNFezf2 subpopulations by viral or tracer injections from the spinal cord of Fezf2-CreER mice. b, PyNFezf2corticospinal neurons in L5B of sensorimotor cortex labelled by retroAAV-flex-tdT. c, Fezf2CreER;Ai14 captures >95% of retrogradely labelled Fluorogold+ corticospinal neurons. Inset arrows indicate Fezf2 and Fluorogold co-labelling. d, An intersection-subtraction (IS) reporter strategy to label projection-defined PyNFezf2 subpopulations (retroAAV-Flp, EGFP) within the overall population (Fezf2-CreER, RFP). e, f, In motor cortex (MO), thalamus-projecting PyNsFezf2 are located in upper L5B, whereas medulla-projecting PyNsFezf2 are located in lower L5B. g, In SSp-bfd, PyNsFezf2 labelled from a defined projection target (EGFP) show more restricted sublaminar position in L5 compared to overall population (RFP). h, Normalized cortical depth distributions of overall PyNFezf2 population (leftward curve) and of each target-defined subpopulation (rightward curves) in SSp-bfd. i, In Fezf2-CreER;Pv-Flp;IS triple allele mice, PV- and PV+ PyNsFezf2 are distinguished by their expression of RFP and EGFP, respectively, in SSp-bfd. j, Sample voltage responses induced by current injection from a pair of PV+ (EGFP) and PV- (RFP) PyNsFezf2 by whole-cell patch recording in a cortical slice., Electrophysiological differences between 5 pairs of PV+ and PV- PyNsFezf2: resting membrane potential (Vm, -66.5 ± 1.6 vs. −70.7 ± 1.5 mV, mean ± s.e.m.; p = 0.0014, Student’s paired t-test); input resistance (MΩ, 60.1 ± 7.8 vs. 108.7 ± 45.4 MΩ, mean ± s.e.m.; p = 0.23, Student’s paired t-test). k, PyNsFezf2 retrogradely labelled from thalamus and medulla are distributed in the upper or lower L5B, respectively, in the motor cortex (related to e, f). In a Fezf2-CreER;IS mouse (upper panels), retroAAV-Flp was injected in thalamus. In a Fezf2-CreER mouse (lower panels), retroAAV-Flex-GFP was injected into the medulla. l-q, Representative hemi-sections containing the SS-bfd showing the labelling patterns of PyNsFezf2, PyNsPlxnd1, PyNsTle4 subsets by retroAAV-Flp injections at subcortical targets (arrows) in PyN-CreER;IS mice. In each panel, the overall PyN-CreER population was labelled by RFP, whereas the target-specific subset expressed EGFP. Corresponding cortical soma depth distribution is shown for Fezf2 hemisections in g, h and to the right for Plxnd1 (p) and Tle4 (q) hemisections (n = 2 for each target). PyNsTle4 project to VPM and consist of two subpopulations with apical dendrites in L4/5 (q’) and L1 (q’’), respectively, indicated by arrows. r, Retrograde targeting of striatum-projecting PyNsPlxnd1 by injection of retroAAV-FLEX-tdTomato in striatum. s, Coronal section displays injection site (arrowhead) and collaterals of retrogradely labelled PyNsPlxnd1 in contralateral striatum (arrow). t-w, Laminar patterns of retrogradely labelled PyNsPlxnd1 reveal that L5A PyNsPlxnd1project to both ipsi- and contralateral striatum, whereas L2/3 PyNsPlxnd1 project to ipsilateral striatum (t, u, v, w). x, Validation of four PyN driver lines by fluorescence in situ hybridization (Plxnd1, Fezf2, Tcerg1l) and antibody (TLE4) using Plxnd1-, Fezf2-, Tcerg1l-CreER driver mice bred with a Rosa26-loxpSTOPloxp-H2bGFP reporter. H2bGFP signal colocalized with mRNA in situ signals of Plxnd1, Fezf2 and Tcerg1l. In Tle4-Cre;Ai14 mice, RFP signals colocalized with immunofluorescence of the TLE4 antibody. Scale bars: b, l-q, 500µm; c, e, g, q’, q’’, x, 50µm; i, s-w, 100µm. Abbreviations explained in the Supplementary Information.
Extended Data Fig. 10 Strategy to target PyN subpopulations combining driver line, projection target and cortical location.
a, Left schematic shows the ‘triple trigger’ strategy for combinatorial targeting by marker, axon target and soma location. Upon Cre and Flp recombination, the dual-tTA reporter expresses the transcription activator, tTA. In a Fezf2-CreER;dual-tTA mouse, tamoxifen induction combined with retrograde retroAAV-Flp injection at the target, cSp5 or SC, activate tTA expression in cSp5- or SC-projection PyNsFezf2 across cortical areas, and AAV-TRE-mRuby anterograde injection at SSp-bfd then labels projection-defined PyNsFezf2 in the SSp-bfd. Coronal images of PyNsFezf2 in SSp-bfd with projection to SC or cSp5, displaying axon collaterals at various subcortical targets, including Str, ZI, thalamus, pons. b, Left schematic depicts the control experiment for use of Cre- and Flp-dependent dual-tTA reporter for target-defined axon projection mapping of PyNsFezf2. Co-injection of a Cre-dependent AAV-DIO-ChR2-EYFP (green, positive control) and tTA-activated AAV-pHB-TRE-mRuby2 (red, negative control), followed by tamoxifen induction, in absence of Flp confirms dependence of reporter on both Cre and Flp recombination. Example images of anterograde injection site (SSp-bfd) and axon projection targets of several indicated ipsi- and contralateral sites displaying EGFP+PyNsFezf2 axons from Cre-dependent AAV, but no mRuby2+ axons (in absence of Flp), demonstrating the dependence of ‘triple trigger’ strategy on intersection of Cre and Flp. Scale bars: a-b, 200 um.
a-c, Retrograde injection of CTB (green) in the lateral striatum labelled a set of contralateral (a, b) and ipsilateral (c) PyNsFezf2 at the top of L5B in SSp-bfd. The whole population of PyNsFezf2 labelled in Fezf2-CreER;Ai14. Depth distributions in c compares total CTB-labelled PyNs (green), CTB+ Fezf2+ (magenta), and the whole population of PyNsFezf2 labelled in Fezf2-CreER;Ai14. d, e), Retrograde injection of CTB in the lateral striatum labelled a set of ipsilateral (d, d’) and contralateral (e, e’) PyNsFezf2 at the top of L5B in MO. f, Fezf2 and Plxnd1 mRNAs are co-expressed (f’, arrows) in a subset of L5 PyNs in the L5B/L5A border region. g, h, Intersection/subtraction mapping in Fezf2-CreER;Plxnd1-Flp;IS mice revealed a small set of PyNsFezf2/Plxnd1 (EGFP) located at the top of L5B among other PyNsFezf2 (RFP). Magnified insets are from the boxed regions in each panel. DAPI (blue) counterstain in c, f-h. Scale bars: a, g, 500µm; b, c, d, e, f, h, 50µm.
This file contains a list of abbreviations, legends for the Supplementary Tables and Videos, and instructions for Data Portal use.
Newly generated mouse driver lines targeting cortical PyNs.
Comparison of new and existing driver lines.
Summary of cell distribution experiments acquired by traditional histology.
Summary of cell distribution datasets acquired by STPT.
Summary of projection datasets acquired by STPT.
Full list of SSp-bfd axon targets and values measured from automated detection. Values report the number of pixels reported per brain structure per dataset on the right and left hemispheres.
Summary of projection datasets acquired by traditional histology.
List of videos acquired by STPT.
Whole-brain STP image stack from Cux1-2A-CreER::Ai14 mouse registered to CCFv3.
Whole-brain STP image stack of anterograde axon projection from right somatosensory cortex from Cux1-2A-CreER;LSL-Flp mouse registered to CCFv3.
Whole-brain STP image stack from Plxnd1-2A-CreER;Snap25-LSL-EGFP mouse registered to CCFv3.
Whole-brain STP image stack from Plxnd1-2A-Flp;FSF-tdTomato mouse registered to CCFv3.
Whole-brain STP image stack of anterograde axon projection from right somatosensory cortex from Plxnd1-2A-CreER;LSL-Flp mouse registered to CCFv3.
Whole-brain STP image stack from Fezf2-2A-CreER;Ai14 mouse registered to CCFv3.
Whole-brain STP image stack of anterograde axon projection from right somatosensory cortex from Fezf2-2A-CreER;LSL-Flp mouse registered to CCFv3.
Whole-brain STP image stack from Adcyap1-2A-CreER;LSL-h2b-GFP mouse registered to CCFv3.
Whole-brain STP image stack of anterograde axon projection from right somatosensory cortex from Adcyap1-2A-CreER;LSL-Flp mouse registered to CCFv3.
Whole-brain STP image stack from Tcerg1l-2A-CreER;LSL-h2b-GFP mouse registered to CCFv3.
Whole-brain STP image stack of anterograde axon projection from right somatosensory cortex from Tcerg1l-2A-CreER mouse registered to CCFv3.
Whole-brain STP image stack from Sema3E-CreER;Ai14 mouse registered to CCFv3.
Whole-brain STP image stack from Tbr1-2A-CreER;Ai14 mouse registered to CCFv3.
Whole-brain STP image stack of anterograde axon projection from right somatosensory cortex from Tbr1-2A-CreER;LSL-Flp mouse registered to CCFv3. 7
Whole-brain STP image stack from Tle4-2A-CreER;Snap25-LSL-EGFP mouse registered to CCFv3.
Whole-brain STP image stack of anterograde axon projection from right somatosensory cortex from Tle4-2A-CreER;LSL-Flp mouse registered to CCFv3.
Whole-brain STP image stack from Foxp2-IRES-Cre mouse expressing AAV9-CAG-DIO-EGFP by systemic injection registered to CCFv3.
Whole-brain STP image stack of anterograde axon projection from right somatosensory cortex from Foxp2-Cre mouse registered to CCFv3.
About this article
Cite this article
Matho, K.S., Huilgol, D., Galbavy, W. et al. Genetic dissection of the glutamatergic neuron system in cerebral cortex. Nature 598, 182–187 (2021). https://doi.org/10.1038/s41586-021-03955-9
Acetylcholine deficiency disrupts extratelencephalic projection neurons in the prefrontal cortex in a mouse model of Alzheimer’s disease
Nature Communications (2022)
Journal of Molecular Neuroscience (2022)